Drug Shortage Report for MENACTRA

Last updated on 2021-08-10 History
Report ID 91659
Drug Identification Number 02279924
Brand name MENACTRA
Common or Proper name Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
Company Name SANOFI PASTEUR LIMITED
Market Status MARKETED
Active Ingredient(s) MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP A MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP C MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP Y MENINGOCOCCAL POLYSACCHARIDE-DIPHTHERIA TOXOID CONJUGATE, GROUP W 135
Strength(s) 4.0MCG 4.0MCG 4.0MCG 4.0MCG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 5 x 0.5 mL vials
ATC code J07AH
ATC description BACTERIAL VACCINES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-08-12
Actual start date 2019-08-12
Estimated end date 2020-03-31
Actual end date 2020-06-30
Shortage status Resolved
Updated date 2021-08-10
Company comments There's a manufacturing delay in 5 x 1 dose vial due to inventory allocated to public program. The 1 x 1 dose vial is available in private market.
Health Canada comments
Tier 3 Status No
Contact Address 1755 STEELES AVENUE WEST
TORONTO, ONTARIO
CANADA M2R 3T4
Company contact information Customer Service/Service à la clientèle: 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-08-15 English Compare
v2 2019-08-15 French Compare
v3 2020-03-04 English Compare
v4 2020-03-04 French Compare
v5 2021-08-10 English Compare
v6 2021-08-10 French Compare

Showing 1 to 6 of 6